Stimulant vs. Nonstimulant ADHD Treatment

Posner Lab

Imaging Study of Stimulant vs. Non-Stimulant Treatment of ADHD
 

What Is ADHD?

Attention-deficit/hyperactivity disorder (ADHD) is one of the most common childhood behavioral disorders, with symptoms that often continue into adolescence and adulthood. Behaviors associated with this disorder include inattention, hyperactivity, and impulsivity. Attention-deficit/hyperactivity disorder (ADHD) is one of the most common childhood behavioral disorders, with symptoms that often continue into adolescence and adulthood. Behaviors associated with this disorder include inattention, hyperactivity, and impulsivity.
 

Research Program Overview

Children with ADHD are typically treated with two types of medications with differing mechanisms of action: stimulants and nonstimulants. Vyvanse (a stimulant medication) and Intuniv (a nonstimulant medication) are both FDA approved treatments for ADHD. This study will utilize magnetic resonance imaging (MRI) to help us better understand how these two medications are effective in treating ADHD. By participating in this study, your child will receive the following, at no cost to you:

  • Full psychiatric evaluation
  • MRI scan
  • Treatment with Vyvanse or Intuniv (only for children with ADHD)
 

Who Is Eligible to Participate?

Participants must:

  • Be between 6 and 17 years old with a diagnosis of ADHD
  • Not be taking any current psychiatric medications or participating in psychotherapy
  • We are also recruiting healthy (control) participants between 6 and 17 years of age
 

Study Procedures

Healthy control participants:

  • Thorough psychiatric evaluation
  • MRI scan

Participants diagnosed with ADHD:

  • Thorough psychiatric evaluations before and after treatment
  • MRI scans before and after treatment
  • Vyvanse or Intuniv
  • 6 weekly sessions with study doctor
 

Compensation

Study testing, medication, and evaluations are provided at no cost to you. You and your child will receive compensation for participation in the study, in addition to reimbursement for transportation, as follows:

  • The maximum amount of compensation child ADHD participants can earn is $300. The maximum amount of compensation their parents can earn is $300.
  • The maximum amount of compensation child healthy control participants can earn is $175.
 

Interested in Learning More?

Contact us!

Jonathan Posner
Phone: 646-774-5863
Email: posnerj@nyspi.columbia.edu